128 related articles for article (PubMed ID: 9628225)
1. Equine monocyte-derived macrophage cultures and their applications for infectivity and neutralization studies of equine infectious anemia virus.
Raabe MR; Issel CJ; Montelaro RC
J Virol Methods; 1998 Mar; 71(1):87-104. PubMed ID: 9628225
[TBL] [Abstract][Full Text] [Related]
2. Equine endothelial cells support productive infection of equine infectious anemia virus.
Maury W; Oaks JL; Bradley S
J Virol; 1998 Nov; 72(11):9291-7. PubMed ID: 9765477
[TBL] [Abstract][Full Text] [Related]
3. DH82 cells: a macrophage cell line for the replication and study of equine infectious anemia virus.
Hines R; Maury W
J Virol Methods; 2001 Jun; 95(1-2):47-56. PubMed ID: 11377712
[TBL] [Abstract][Full Text] [Related]
4. Monocyte maturation controls expression of equine infectious anemia virus.
Maury W
J Virol; 1994 Oct; 68(10):6270-9. PubMed ID: 8083967
[TBL] [Abstract][Full Text] [Related]
5. Phorbol ester stimulation of equine macrophage cultures alters expression of equine infectious anemia virus.
Sellon DC; Walker KM; Russell KE; Perry ST; Fuller FJ
Vet Microbiol; 1996 Oct; 52(3-4):209-21. PubMed ID: 8972047
[TBL] [Abstract][Full Text] [Related]
6. Characterization of an equine macrophage cell line: application to studies of EIAV infection.
Fidalgo-Carvalho I; Craigo JK; Barnes S; Costa-Ramos C; Montelaro RC
Vet Microbiol; 2009 Apr; 136(1-2):8-19. PubMed ID: 19038510
[TBL] [Abstract][Full Text] [Related]
7. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain.
Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K
Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667
[TBL] [Abstract][Full Text] [Related]
8. Change in host cell tropism associated with in vitro replication of equine infectious anemia virus.
Carpenter S; Chesebro B
J Virol; 1989 Jun; 63(6):2492-6. PubMed ID: 2470916
[TBL] [Abstract][Full Text] [Related]
9. Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection.
Du C; Ma J; Liu Q; Li YF; He XJ; Lin YZ; Wang XF; Meng QW; Wang X; Zhou JH
Retrovirology; 2015 Apr; 12():36. PubMed ID: 25928027
[TBL] [Abstract][Full Text] [Related]
10. Proteomic alteration of equine monocyte-derived macrophages infected with equine infectious anemia virus.
Du C; Liu HF; Lin YZ; Wang XF; Ma J; Li YJ; Wang X; Zhou JH
Proteomics; 2015 Jun; 15(11):1843-58. PubMed ID: 25684102
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin treatment of equine infectious anaemia virus-infected horse macrophage cultures decreases production of infectious virus.
Smith TA; Davis E; Carpenter S
J Gen Virol; 1998 Apr; 79 ( Pt 4)():747-55. PubMed ID: 9568970
[TBL] [Abstract][Full Text] [Related]
12. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.
Harrold SM; Cook SJ; Cook RF; Rushlow KE; Issel CJ; Montelaro RC
J Virol; 2000 Apr; 74(7):3112-21. PubMed ID: 10708426
[TBL] [Abstract][Full Text] [Related]
13. Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication.
Li F; Chen C; Puffer BA; Montelaro RC
J Virol; 2002 Feb; 76(4):1569-77. PubMed ID: 11799151
[TBL] [Abstract][Full Text] [Related]
14. Equine infectious anemia virus derived from a molecular clone persistently infects horses.
Whetter L; Archambault D; Perry S; Gazit A; Coggins L; Yaniv A; Clabough D; Dahlberg J; Fuller F; Tronick S
J Virol; 1990 Dec; 64(12):5750-6. PubMed ID: 2173767
[TBL] [Abstract][Full Text] [Related]
15. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
[TBL] [Abstract][Full Text] [Related]
16. In vitro antibody-dependent enhancement assays are insensitive indicators of in vivo vaccine enhancement of equine infectious anemia virus.
Raabe ML; Issel CJ; Montelaro RC
Virology; 1999 Jul; 259(2):416-27. PubMed ID: 10388665
[TBL] [Abstract][Full Text] [Related]
17. Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection.
Chen C; Li F; Montelaro RC
J Virol; 2001 Oct; 75(20):9762-70. PubMed ID: 11559809
[TBL] [Abstract][Full Text] [Related]
18. Differential responses of Equus caballus and Equus asinus to infection with two pathogenic strains of equine infectious anemia virus.
Cook SJ; Cook RF; Montelaro RC; Issel CJ
Vet Microbiol; 2001 Mar; 79(2):93-109. PubMed ID: 11230932
[TBL] [Abstract][Full Text] [Related]
19. Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum.
Tang YD; Na L; Zhu CH; Shen N; Yang F; Fu XQ; Wang YH; Fu LH; Wang JY; Lin YZ; Wang XF; Wang X; Zhou JH; Li CY
J Virol; 2014 Nov; 88(21):12296-310. PubMed ID: 25122784
[TBL] [Abstract][Full Text] [Related]
20. Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes.
Sellon DC; Perry ST; Coggins L; Fuller FJ
J Virol; 1992 Oct; 66(10):5906-13. PubMed ID: 1382143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
